Picture of Indaptus Therapeutics logo

INDP — Indaptus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Intec Pharma: Surges on research tie-up with Merck

** Shares of Israel-based drug developer  NTEC.O  jump 20.9%
to $0.31 premarket, their highest level in more than one month
    ** Co says it entered into a research collaboration
agreement with Merck & Co  MRK.N ; Says details of the agreement
are confidential  urn:newsml:reuters.com:*:nPn8C9XfVa
    ** Stock set for its best day since late-July
    ** NTEC down 49.3% this year by its last close

 (Reporting by Ambar Warrick in Bengaluru)
 ((Ambar.Warrick@thomsonreuters.com; +91-80-6182-2837; Reuters
Messaging: ambar.warrick.thomsonreuters.com@reuters.net;
Twitter: @AmbarWarrick))

Recent news on Indaptus Therapeutics

See all news